Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List 2026-05-27 17:43
Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer 2026-05-26 19:30
Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session 2026-05-26 12:35
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting 2026-05-25 18:56
Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations 2026-05-22 11:30
Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026 2026-05-22 08:00
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting 2026-05-22 05:34
Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026 2026-05-22 05:00
Fox ESS Celebrates Strong Momentum with Integrated Solar Storage & Charging Solutions at Smart Energy 2026 2026-05-09 10:17
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA 2026-05-08 19:29
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution 2026-04-28 22:54
139th Canton Fair: Creativity and Innovation Sparks New Possibilities in Gifts & Decorations Category 2026-04-25 23:00
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations 2026-04-23 15:02
2026 ASCO Preview | Alphamab Oncology to Present Clinical Data of TROP2/HER3 Bispecific ADC JSKN016 for HER2-Negative Breast Cancer 2026-04-23 10:19
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation 2026-04-22 14:10
Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting 2026-04-22 08:59
Innovent to Present New Clinical Data of IBI363（PD-1/IL-2α-biased bispecific fusion protein） at the 2026 ASCO Annual Meeting 2026-04-22 08:00
ViGenCell's VT-EBV-N Selected for Oral Presentation at ASCO 2026 2026-04-22 07:30
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity 2026-04-16 20:49
Mexican company Farmacias Similares brings Dr. Simi to Tokyo in Japan debut 2026-04-15 06:00
1 2 3 4 5 6 8